GGrantIndex
← Leaderboards

Bernard Pragash Arulanandam

University Of Texas San Antonio

$4,346,773
Attributed
$4,346,773
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $591.9K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,346,773 · 8

By mechanism

R01$1,892,570 · 1
P01$1,118,987 · 1
R21$849,056 · 2
R03$471,160 · 3
R13$15,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas San Antonio

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionProteinsVaccinesImmunityVaccinationVaccinatedAntigensInsightMediatingBaseCd4 Positive T LymphocytesLicensingPathologyImmuneImmunizationRecombinantsAnimalsOrganismMacrophageDesignBacterial Sexually Transmitted DiseasesCellsInflammatoryFemale

Grant awards (23)

Evaluation of a polypeptide vaccine against Acinetobacter infection$193,591
R21 · FY2025 · AI · contact PI
Evaluation of a polypeptide vaccine against Acinetobacter infection$251,215
R21 · FY2024 · AI · contact PI
San Antonio Military Health System and Universities Research Forum (SURF)$15,000
R13 · FY2018 · TR · contact PI
Thioredoxin mediated Acinetobacter baumannii colonization in the GI tract$220,500
R21 · FY2017 · AI · contact PI
The Contribution of MicroRNA-182 in Genital Chlamydia trachomatis Infection$73,500
R03 · FY2017 · AI · contact PI
Thioredoxin mediated Acinetobacter baumannii colonization in the GI tract$183,750
R21 · FY2016 · AI · contact PI
The Contribution of MicroRNA-182 in Genital Chlamydia trachomatis Infection$73,500
R03 · FY2016 · AI · contact PI
CPAF induced CD4+ T cell mediated immunity against Chlamydia$332,818
R01 · FY2013 · AI · contact PI
CPAF induced CD4+ T cell mediated immunity against Chlamydia$354,061
R01 · FY2012 · AI · contact PI
Evaluation of CPAF Mediated Anti-Chlamydial Immunity in the Guinea Pig$72,250
R03 · FY2012 · AI · contact PI
CPAF induced CD4+ T cell mediated immunity against Chlamydia$354,061
R01 · FY2011 · AI · contact PI
Evaluation of CPAF Mediated Anti-Chlamydial Immunity in the Guinea Pig$72,250
R03 · FY2011 · AI · contact PI
CPAF induced CD4+ T cell mediated immunity against Chlamydia$357,638
R01 · FY2010 · AI · contact PI
CPAF induced CD4+ T cell mediated immunity against Chlamydia$132,742
R01 · FY2010 · AI · contact PI
CPAF induced CD4+ T cell mediated immunity against Chlamydia$361,250
R01 · FY2009 · AI · contact PI
Mapping of F. tularensis T cell epitopes in Humanized Mice$230,617
P01 · FY2009 · AI · contact PI
Mapping of F. tularensis T cell epitopes in Humanized Mice$225,457
P01 · FY2008 · AI · contact PI
Mapping of F. tularensis T cell epitopes in Humanized Mice$221,680
P01 · FY2007 · AI · contact PI
Mapping of F. tularensis T cell epitopes in Mice$221,107
P01 · FY2006 · AI · contact PI
Mapping of F. tularensis T cell epitopes in Mice$220,126
P01 · FY2005 · AI
The Role of IgA in S. aureus Mediated Inflammation$60,212
R03 · FY2004 · AR
The Role of IgA in S. aureus Mediated Inflammation$59,915
R03 · FY2003 · AR
The Role of IgA in S. aureus Mediated Inflammation$59,533
R03 · FY2002 · AR